Blog
RSS FeedPosted by Michael Wonder on 13 Sep 2021
1 October 2021 price disclosure confirmed prices
13 September 2021 - Confirmed 1 October 2021 prices resulting from the 2021 October cycle of price disclosure have now been ...
Posted by Michael Wonder on 12 Aug 2021
Thousands of south Aucklanders could benefit from Medsafe approving new diabetes drug
12 August 2021 - Medsafe’s approval of a new drug for type 2 diabetes could dramatically change the lives of ...
Posted by Michael Wonder on 05 Aug 2021
Canadian agency loses a battle in effort to force a drug maker to lower ‘excessive’ pricing
4 August 2021 - In a withering ruling, a Canadian appeals court overturned a controversial decision issued four years ago ...
Posted by Michael Wonder on 05 Aug 2021
Pfizer epilepsy drug prices were 'unfairly high,' UK review finds
5 August 2021 - Britain's competition watchdog is sticking with its view that Pfizer and Flynn Pharma broke the law ...
Posted by Michael Wonder on 04 Aug 2021
Court topples Canadian ruling that one of world's most expensive drugs is excessively priced
3 August 2021 - Soliris was originally approved to treat two blood disorders affecting about 180 Canadians, with the list price ...
Posted by Michael Wonder on 29 Jul 2021
Advanz and private equity groups fined for 1,000 per cent drug price hike
29 July 2021 - Regulator penalises pharma company and buyout firms Cinven and Hg after NHS hit by ‘unfair’ rises. ...
Posted by Michael Wonder on 15 Jul 2021
Pharma companies fined after 10,000% price rise for life saving drug
15 July 2021 - UK watchdog imposes £260 million in penalties for increases in costs of hydrocortisone tablets. ...
Posted by Michael Wonder on 04 Jul 2021
COVID-19 indemnity scheme to protect health professionals and patients
2 July 2021 - The Australian Government is establishing a COVID-19 Vaccine Claim Scheme to provide further assurance and confidence to ...
Posted by Michael Wonder on 30 Jun 2021
Canada again delays overhaul to patented medicine pricing system
29 June 2021 - Health Minister Patty Hajdu is delaying the first big overhaul of Canada’s patented medicines pricing system ...
Posted by Michael Wonder on 24 Jun 2021
PMPRB risks harming the health of Canadians by reducing access to new medicines
23 June 2021 - On June 21, Innovative Medicines Canada submitted six recommendations to the federal government as part of the ...
Posted by Michael Wonder on 16 Jun 2021
German law makers seek to ease reimbursement for advanced therapies
15 June 2021 - Advanced therapy trade group The Alliance for Regenerative Medicine has highlighted the passage of a new ...
Posted by Michael Wonder on 05 Jun 2021
Put Canadians first by suspending the implementation of harmful drug pricing regulations
4 June 2021 - Innovative Medicines Canada calls on the federal government to suspend the implementation of the Patented Medicines ...
Posted by Michael Wonder on 31 May 2021
New EU health innovation rules edge closer
29 May 2021 - Three years after the original proposal, the European Union’s game changing Health Technology Assessment dossier has ...
Posted by Michael Wonder on 19 May 2021
Government to introduce new law for vaccine after legal challenge
19 May 2021 - The Government will introduce legislation on Wednesday to ensure the COVID-19 vaccination programme can continue, after ...
Posted by Michael Wonder on 06 May 2021
Alberta, Canada, begins mandating switches from originator to biosimilar Humira
6 May 2021 - Alberta, Canada becomes the latest province to begin switching patients from originator adalimumab (Humira) to biosimilar ...